HUONS Changes Extraordinary General Meeting to August 21, 2026 to Approve Merger and Expand Business Objectives
HUONS resolved to change the schedule of its extraordinary general meeting from July 16, 2026 to August 21, 2026.
The agenda includes approval of a merger and amendment of articles of incorporation (addition/modification of business objectives) to reflect the target company's business purposes.
Business objectives to be added/modified include biological product R&D, biopharmaceuticals, cosmetics, veterinary drugs, food, medical devices, etc.
[AI Comprehensive Analysis]This filing is a correction due to a schedule change and does not directly affect shareholder value. However, the merger and expansion of business objectives signal the company's future growth direction, warranting long-term attention.
KOSDAQ Filing Information
Filing: [Correction of Description] Resolution on Convening of General Meeting of Shareholders (Extraordinary General Meeting)